Abhushan Poudyal, MD
Cardiovascular Disease · Portland, ORNPI 1497107189
Payments from drug & device makers
What this record shows
This record is dominated by grants: $41,000 of the $54,301 with a category attached, or 75.5%. 13 manufacturers reported payments, led by Medtronic at 42.6% of the total. Reporting peaked in 2023 at $46,081 and has fallen 90.2% since, to $4,529 in 2025. Among cardiovascular disease clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $369.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$23K
- Boston Scientific$21K
- Edwards Lifesciences$5K
- Abbott$4K
- Inari Medical, Inc.$418
- Penumbra, Inc.$278
- plus $868 from 7 others
What the payments were for
- Grants$41,00076%
- Travel & lodging$6,90313%
- Food & beverage$6,30712%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 32 | $23,156 |
| Boston Scientific | 16 | $21,431 |
| Edwards Lifesciences | 54 | $4,526 |
| Abbott | 28 | $3,623 |
| Inari Medical, Inc. | 6 | $418 |
| Penumbra, Inc. | 2 | $278 |
| Novo Nordisk | 2 | $225 |
| Shockwave Medical, Inc | 1 | $157 |
| Cardiva Medical, Inc. | 1 | $123 |
| Cardiovascular Systems Inc. | 1 | $98 |
| Abiomed | 1 | $94 |
| Astellas Pharma US Inc | 1 | $89 |
| Teleflex LLC | 2 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$22,082
- TRICLIP$1,359
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,290
- AMPLATZER AMULET$1,077
- VersaCross Access Solution$669
- FLOWTRIEVER CATHETER, S$279
- CT THROMBECTOMY SYSTEM KIT$279
- Indigo System$278
- ESPRIT$174
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$157
- EVOQUE$151
- SAPIEN 3 Ultra RESILIA$149
- Watchman$145
- EKOSONIC$135
- COMPLETE SE VASCULAR$131
- OPTIS$127
- Cardiva VASCADE 6/7F VCS$123
- COROFLOW$121
- Ozempic$115
- PASCAL$111
How this compares
$54,301 in reported general payments places this provider in the 95th percentile of 198 cardiovascular disease providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $12,367 |
| Torsemide | 11 | $250 |
| Atorvastatin Calcium | 12 | $193 |
| Potassium Chloride | 13 | $64 |
| Furosemide | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Portland
- Firas ZahrPortland$810K
- Scott ChadderdonPortland$282K
- Ahmad MasriPortland$227K
- Stephen HeitnerPortland$105K
- Douglas DawleyPortland$45K
- Kishor KhanalPortland$39K
- Jeffrey MarbachPortland$19K
- Laith AlkukhunPortland$16K
- Tyler GluckmanPortland$15K
- Sylvia Marie BisoPortland$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.